Stock Highlights: JinkoSolar Holding Co., Ltd. (NYSE:JKS), Cleveland BioLabs, Inc. (NASDAQ:CBLI), M/I Homes, Inc. (NYSE:MHO), Mattersight Corporation (NASDAQ:MATR), Trevena, Inc. (NASDAQ:TRVN)

On 10 July, JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares increased 3.64% and was closed at $25.34. JKS EPS growth in last 5 year was 51.60%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) year to date (YTD) performance is 28.56%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) is scheduled to next report earnings for the current quarter on 2015-08-17.

Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares increased 4.71% in last trading session and ended the day at $3.78. CBLI return on assets is -3.30%. Cleveland BioLabs, Inc. (NASDAQ:CBLI) quarterly performance is 3.00%. On 10 July, Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced the appointment of Mses. Anna Evdokimova, Natalia Khudyk, Yulia Lebedina, Tatiana Levina, Natalia Saraeva, and Mssrs. Konstantin Gorshkov and Ivan Persiyanov to the Company’s Board of Directors. These directors were appointed in connection with a private sale of securities to David Davidovich in July 2015.

On 10 July, M/I Homes, Inc. (NYSE:MHO) shares increased 1.82% and was closed at $25.12. MHO EPS growth in last 5 year was 19.30%. M/I Homes, Inc. (NYSE:MHO) year to date (YTD) performance is 9.41%. M/I Homes, Inc. (NYSE:MHO) announced that, it will release Second Quarter Earnings Webcast on 23 July.

Mattersight Corporation (NASDAQ:MATR) ended the last trading day at $6.47. Company weekly volatility is calculated as 4.99% and price to cash ratio as 9.95. Mattersight Corporation (NASDAQ:MATR) showed a weekly performance of 14.92%. On 7 July, Mattersight Corporation (NASDAQ:MATR) provided an update on its second quarter business activity. Total revenue growth guidance is increased to 33% to 38%, up from 30% to 35%. Total subscription growth guidance is increased to 38% to 43%, up from 35% to 40%

Trevena, Inc. (NASDAQ:TRVN) shares advanced 10.34% in last trading session and ended the day at $6.51. TRVN return on assets is -57.50%. Trevena, Inc. (NASDAQ:TRVN) quarterly performance is -4.26%. Wedbush reiterated their outperform rating on shares of Trevena, Inc. (NASDAQ:TRVN) in a research note released on Thursday morning. They currently have a $15.00 target price on the biopharmaceutical company’s stock.

Leave a Reply

Your email address will not be published. Required fields are marked *